18:38:52 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Loblaw Companies Ltd
Symbol L
Shares Issued 412,730,072
Close 2014-04-29 C$ 45.80
Market Cap C$ 18,903,037,298
Recent Sedar Documents

Loblaw Companies earns $103-million in Q1 2014

2014-04-30 07:43 ET - News Release

Mr. Galen Weston reports

LOBLAW COMPANIES LIMITED REPORTS 2014 FIRST QUARTER RESULTS AND ANNOUNCES 2.1% INCREASE TO QUARTERLY COMMON SHARE DIVIDEND

Loblaw Companies Ltd. has released its unaudited financial results for the first quarter ended March 22, 2014. The company's first-quarter report will be available in the investor centre section of the company's website and will be filed with SEDAR.

On March 28, 2014, subsequent to the end of the first quarter of 2014, the company completed the acquisition of Shoppers Drug Mart Corp. A summary of Shoppers Drug Mart operating results for the first quarter ended March 22, 2014, is included as an addendum to this news release.

First-quarter highlights:

  • Revenue of $7,292-million, an increase of 1.2 per cent over the first quarter of 2013;
  • Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) up 5.0 per cent to $463-million compared with $441-million in the first quarter of 2013;
  • Adjusted basic net earnings per common share up 2.1 per cent to 49 cents compared with 48 cents in the first quarter of 2013;
  • Basic net earnings per common share down 39.3 per cent to 37 cents compared with 61 cents in the first quarter of 2013, with 2013 positively impacted by a gain related to defined benefit plan amendments;
  • Retail sales growth of 0.8 per cent and same-store sales growth of 0.9 per cent compared with the first quarter of 2013;
  • Retail same-store sales growth was negatively impacted by approximately 0.2 per cent due to the shift in the timing of Easter;
  • Normalized for the shift, same-store sales growth for the quarter was approximately 1.1 per cent;
  • Financial services revenue increased by 9.1 per cent over the first quarter of 2013;
  • Quarterly common share dividend increase of approximately 2.1 per cent, from 24 cents per common share to 24.5 cents per common share.

"The first quarter of 2014 marked another quarter of steady progress in our core business," said Galen G. Weston, executive chairman, Loblaw Companies. "We remained focused on balancing our commitment to competitiveness and financial performance, achieving positive same-store sales and growing adjusted operating income. While the industry backdrop continues to be challenging with the intensely competitive market environment and the continued impact of drug reform, we still expect to advance our combined business both financially and operationally this year.

"With the acquisition of Shoppers Drug Mart completed, we are able to move into the next chapter for Loblaw, as we continue to build a portfolio of strong, complementary and independent businesses," continued Mr. Weston. "The near-term financial benefits, as well as the long-term strategic rationale of this transaction are extremely compelling."

The $90-million increase in revenue compared with the first quarter of 2013 was primarily driven by an increase in the company's retail segment. Revenue also increased in the company's financial services segment.

Operating income decreased by $56-million compared with the first quarter of 2013. The change in operating income was negatively impacted by the gain related to defined benefit plan amendments recorded in the first quarter of 2013, costs related to the acquisition of Shoppers Drug Mart, general and administrative costs related to Choice Properties Real Estate Investment Trust, and unfavourable year-over-year changes in fixed-asset and other related impairments. Adjusted operating income increased by $10-million compared with the first quarter of 2013, primarily driven by an increase in adjusted operating income in the company's financial services segment.

Adjusted operating margin was 3.7 per cent for the first quarter of 2014 compared with 3.6 per cent in the same quarter in 2013. Adjusted EBITDA margin was 6.3 per cent for the first quarter of 2014 compared with 6.1 per cent in the same quarter in 2013.

Net interest expense and other financing charges increased by $39-million compared with the first quarter of 2013 and included net interest of $15-million related to indebtedness incurred to finance the acquisition of Shoppers Drug Mart, and an unfavourable $12-million fair value adjustment related to the trust unit liability for the change in the fair value of Choice Properties' trust units held by unitholders other than the company. Excluding these impacts net interest expense and other financing charges increased by $12-million, driven primarily by distributions paid by Choice Properties on its units and by higher interest on long-term debt.

Income tax expense for the first quarter of 2014 was $35-million (2013 -- $62-million) and the effective income tax rate was 25.4 per cent (2013 -- 26.6 per cent). The decrease in the effective tax rate over the first quarter of 2013 was primarily due to an increase in income tax recoveries related to prior-year tax matters, partially offset by an increase in non-deductible amounts, including fair value adjustments on the trust unit liability. After excluding the tax impact of items excluded from adjusted net earnings, the effective income tax rate on adjusted net earnings was 22.8 per cent (2013 -- 26.4 per cent).

Net earnings decreased by $68-million compared with the first quarter of 2013, primarily driven by the decrease in operating income and the increase in net interest expense and other financing charges described above, partially offset by a lower income tax expense. Adjusted net earnings increased by $5-million compared with the first quarter of 2013, primarily driven by higher adjusted operating income and a lower effective income tax rate on adjusted net earnings, partially offset by higher net interest and other financing charges after excluding certain items described above.

Basic net earnings per common share were 37 cents in the first quarter of 2014 compared with 61 cents in the first quarter of 2013. Adjusted basic net earnings per common share were 49 cents in the first quarter of 2014 compared with 48 cents in the first quarter of 2013.

In the first quarter of 2014, the company invested $116-million (2013 -- $119-million) in capital expenditures.

Retail segment

In the first quarter of 2014, the increase in retail sales of $58-million, or 0.8 per cent, over the same period in the prior year was a result of the following factors:

  • Same-store sales growth was 0.9 per cent (2013 -- 2.8 per cent) and was negatively impacted by approximately 0.2 per cent due to the shift in the timing of Easter. Normalized for the shift, same-store sales growth for the quarter was approximately 1.1 per cent.
  • Same-store sales growth excluding gas bar for the quarter was 0.8 per cent (2013 -- 2.8 per cent) and normalized for the effect of the shift in the timing of Easter, was approximately 1.0 per cent.
  • Sales growth in food was moderate.
  • Sales in drugstore declined marginally.
  • Sales growth in gas bar was moderate.
  • Sales in general merchandise, excluding apparel, were flat.
  • Sales in apparel were flat.
  • The company's average quarterly internal food price index was slightly higher (2013 -- lower) than the average quarterly national food price inflation of 1.2 per cent (2013 -- 1.4 per cent) as measured by the Consumer Price Index for Food Purchased from Stores. CPI does not necessarily reflect the effect of inflation on the specific mix of goods sold in Loblaw stores.
  • Twenty-three corporate and franchise stores were opened and 12 corporate and franchise stores were closed in the last 12 months, resulting in a net increase of 400,000 square feet, or 0.8 per cent.

In the first quarter of 2014, gross profit percentage was 22.3 per cent, down 10 basis points compared with the first quarter of 2013. The decline was primarily driven by higher shrink due to the investment in fresh assortment and increased transportation costs, which were mainly the result of higher fuel prices. Gross profit dollars increased by $4-million, or 0.3 per cent, compared with the same period in 2013, driven by higher sales partially offset by the decline in gross profit percentage.

Operating income decreased by $62-million compared with the first quarter of 2013, and was negatively impacted by the gain related to defined benefit plan amendments recorded in the first quarter of 2013, costs related to the acquisition of Shoppers Drug Mart and unfavourable year-over-year changes in fixed-asset and other related impairments. Adjusted operating income decreased by $2-million compared with the first quarter of 2013, primarily driven by increased other operating costs, including depreciation and amortization, higher foreign exchange losses, and costs related to certain of the company's emerging businesses, partially offset by supply chain and labour efficiencies, and higher gross profit. For the first quarter of 2014, adjusted operating margin was 3.2 per cent, flat compared with the same period in 2013.

Adjusted EBITDA increased by $8-million compared with the first quarter of 2013. For the first quarter of 2014 adjusted EBITDA margin was 5.9 per cent compared with 5.8 per cent in the same period in 2013. Retail segment depreciation and amortization increased by $10-million compared with the first quarter of 2013.

Financial services segment

Revenue for the first quarter of 2014 increased by 9.1 per cent compared with the first quarter of 2013. This increase was primarily driven by higher interest income from higher credit card receivable balances and an increased interest income yield, and higher other service-fee-related income.

Operating income and earnings before income taxes increased by $6-million and $4-million, respectively, compared with the first quarter of 2013. These increases were mainly attributable to higher revenue as described above, partially offset by higher operating costs as a result of an increase in the active customer base, and higher credit losses.

As at March 22, 2014, credit card receivables were $2,399-million, an increase of $224-million compared with March 23, 2013. This increase was primarily driven by growth in the active customer base as a result of continued investments in customer acquisitions and marketing initiatives over the past two years. As at March 22, 2014, the allowance for credit card receivables was $47-million, an increase of $4-million compared with March 23, 2013, primarily due to the growth in the credit card portfolio.

Choice Properties segment

Revenue for the first quarter of 2014 was $167-million, of which $150-million was received from the retail segment. Revenue consists of base rent, operating cost and property tax recoveries.

Operating income for the first quarter of 2014 was $118-million and included $5-million of general and administrative costs. Adjusted operating income was $124-million.

Net operating income for the first quarter of 2014 was $115-million, which consisted of cash rental revenue less property operating costs.

Funds from operations and adjusted funds from operations for the first quarter of 2014 were $87-million and $69-million, respectively.

Results of Choice Properties operations for the first quarter of 2014 were slightly better than the financial forecast included in Choice Properties' equity and debt prospectuses dated June 26, 2013, primarily driven by incremental income from properties acquired since that date.

In the first quarter of 2014, Choice Properties completed the issuance of $450-million principal amount of senior unsecured debentures. The majority of the proceeds were used to repay $440-million of transferor notes held by Loblaw.

Also in the first quarter of 2014, Choice Properties acquired an industrial property in Mississauga, Ont., for approximately $16-million. The acquisition was financed entirely with cash. This property is fully leased to a related party.

Acquisition of Shoppers Drug Mart

On March 28, 2014, subsequent to the end of the first quarter, the company acquired all of the outstanding shares of Shoppers Drug Mart for total consideration of $12.3-billion, comprising approximately $6.6-billion of cash and the issuance of approximately 119.5 million common shares of the company.

The cash portion of the acquisition was financed as follows:

  • $3.5-billion was obtained through an unsecured term loan facility bearing interest at a rate equal to the bankers' acceptance rate plus 1.75 per cent and maturing March 28, 2019;
  • $1.6-billion of proceeds from the issuance of unsecured notes in the third quarter of 2013 were released from escrow;
  • $500-million was received in consideration of the issuance of 10.5 million common shares to George Weston Ltd.;
  • Approximately $1.0-billion was used from cash on hand.

Loblaw expects to achieve annualized synergies of $300-million in the third full year following the close of the transaction (net of related costs), phased in evenly over three years. First-year synergies are expected to be generated primarily from improved cost of goods sold and from purchasing efficiencies in goods not for resale.

Pursuant to a consent agreement reached with the Competition Bureau in the first quarter of 2014, the company is required to divest of 14 Shoppers Drug Mart stores and four of the company's franchise grocery stores, as well as nine pharmacy operations of the company. The divestitures are not expected to have a material impact on the operations of the company or the planned synergies.

Based on a preliminary assessment, the company expects to recognize amounts of net tangible assets, goodwill and intangible assets in the second quarter of 2014 as shown in the associated table.

                          NET TANGIBLE ASSETS, GOODWILL AND INTANGIBLE ASSETS 
                         (millions of dollars except where otherwise indicated) 
                                                                                              Estimated 
                                                                                            useful life
Fair value of net tangible assets acquired                                 $   552                     
Goodwill                                                                     2,251                     
Prescription files                                                           5,040             11 years
Brands                                                                       3,340           indefinite
Optimum loyalty program                                                        490             18 years
Other                                                                          600        5 to 10 years
Total intangible assets                                                      9,470                     
Total net assets acquired                                                  $12,273                     

The company anticipates annual amortization of approximately $550-million relating to the intangible assets. In addition, other purchase-related fair value adjustments will be recognized, including a fair value adjustment to inventory of approximately $800-million, representing the difference between inventory cost and its fair value. This difference will be recognized in cost of sales as the inventory is sold over the remainder of 2014, with a resulting negative impact on gross profit. The company will exclude these impacts in calculating adjusted operating income, as management does not consider them to be reflective of the company's underlying operating performance.

In the first quarter of 2014, the company incurred costs related to the acquisition of $23-million, of which $8-million was recorded in selling, general and administrative expenses and $15-million was recorded in net interest expense and other financing charges.

Upon closing of the acquisition, all amounts owing on Shoppers Drug Mart's revolving bank credit facility were repaid and the facility was cancelled. In addition, upon closing, the company guaranteed the outstanding principal amount of Shoppers Drug Mart medium-term notes of $500-million, along with any accrued interest. The company has also provided guarantees to various Canadian banks in support of the financing obtained by Shoppers Drug Mart associates.

Declaration of dividends

Subsequent to the end of the first quarter of 2014, the board of directors declared a quarterly dividend on Loblaw Companies common shares of 24.5 cents payable July 1, 2014, to shareholders of record on June 15, 2014, and a dividend on the second preferred shares, Series A, of 37 cents per share payable July 31, 2014, to shareholders of record on July 15, 2014.

Outlook

The company expects to update this outlook in the second-quarter earnings announcement, which will reflect the impacts of:

  • Accounting policies alignment and the purchase price allocation with respect to the acquisition of Shoppers Drug Mart;
  • Synergies expected to be achieved in 2014. The company's overall synergy targets remain unchanged.

The company expects the competitive environment and industry square footage to remain at historically high levels in the second quarter, and also expects deflationary pressure from regulatory drug reform -- the impacts of which are expected to moderate in the second half of the year. During the second quarter, the company also anticipates to be negatively impacted by the timing of charges related to the transition of certain stores to more cost-effective and efficient operating terms under collective agreements. These charges are anticipated to be approximately $25-million. Expectations for the full year with respect to these charges are approximately $35-million. In 2013, the charges were $8-million and $24-million, for the second quarter and full year, respectively.

                          CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
                          (millions of dollars except per share amounts)

                                                               March 22, 2014   March 23, 2013
                                                                   (12 weeks)       (12 weeks)

Revenue                                                              $  7,292       $   7,202 
Cost of merchandise inventories sold                                    5,528           5,474 
Selling, general and administrative expenses                            1,511           1,419 
                                                                     --------       ---------
Operating income                                                          253             309 
Net interest expense and other financing charges                          115              76 
                                                                     --------       ---------
Earnings before income taxes                                              138             233 
Income taxes                                                               35              62 
                                                                     --------       ---------
Net earnings                                                         $    103       $     171
                                                                     ========       =========
Net earnings per common share                                                              
Basic                                                                $   0.37       $    0.61
Diluted                                                                  0.36            0.60

Addendum -- Shoppers Drug Mart results

On March 28, 2014, subsequent to the end of the first quarter of 2014, the company completed the acquisition of Shoppers Drug Mart. As Shoppers Drug Mart is no longer a public issuer, it was not required to file a quarterly report for the first quarter of 2014. Beginning in the second quarter of 2014, Shoppers Drug Mart operating results will be included within the retail operating segment of the company.

                       SHOPPERS DRUG MART RESULTS
                        (in millions of dollars)

                                            For the periods ended 
                                       March 22,         March 23, 
                                           2014              2013   
                                     (12 weeks)         (12 weeks) 
 
Sales                                   $ 2,518          $  2,486  
Cost of goods sold                        1,552             1,529  
                                        -------          --------
Gross profit                                966               957  
Operating and administrative expenses       796               782  
                                        -------          --------
Operating income                            170               175  
Adjusted operating income                   177               175  
EBITDA                                      243               250  
Adjusted EBITDA                             250               250  

The following provides an overview of Shoppers Drug Mart's operating performance for the quarter ended March 22, 2014, compared with the quarter ended March 23, 2013:

  • Sales were $2.5-billion, an increase of 1.3 per cent over the same period of the prior year, driven by sales gains in the front of the store and continued strength in prescription count growth. On a same-store basis, sales increased 1.4 per cent in the quarter.
  • Pharmacy sales were $1.2-billion, an increase of 0.5 per cent compared with the same period of the prior year, as strong growth in the number of prescriptions filled at retail was partially offset by a further reduction in average prescription value. On a same-store basis, pharmacy sales increased by 0.4 per cent in the quarter. During the first quarter of 2014, the number of prescriptions dispensed at retail increased by 4.1 per cent compared with the same period of the prior year and was up 4.0 per cent on a same-store basis. Year over year, average prescription value at retail declined by 3.0 per cent during the first quarter of 2014, largely as a result of further reductions in generic prescription reimbursement rates due to continuing drug system reform initiatives, along with increasing generic prescription utilization rates. Generic molecules made up 62.5 per cent of the prescriptions dispensed in the first quarter of 2014 compared with 60.7 per cent in the same period last year.
  • Front-store sales were $1.3-billion, an increase of 2.1 per cent compared with the same period of the prior year, led by strong growth in cosmetics, food and confection and beverage. On a same-store basis, front-store sales increased by 2.2 per cent during the first quarter of 2014.
  • During the first quarter, four new drug stores were opened, one of which was a relocation, one drug store was acquired and four smaller pharmacy formats were closed. Year over year, retail selling square footage increased by 2.1 per cent.

Operating income, inclusive of transaction-related costs of $7 million associated with the acquisition of Shoppers Drug Mart by Loblaw, was $170-million in the first quarter of 2014. Excluding the impact of these transaction-related costs, adjusted operating income for the first quarter of 2014 was $177-million compared with adjusted operating income of $175-million in the same period of the prior year. Year over year, gross profit dollars increased by 0.9 per cent in the first quarter of 2014, as the level of promotional intensity in the market remained high. Operating and administrative expenses, including depreciation and amortization expense, increased 1.7 per cent compared with the same period last year. Excluding the impact of the aforementioned transaction-related costs of $7-million, first quarter adjusted operating and administrative expenses were up 0.9 per cent year over year, driven largely by higher store-level expenses, primarily occupancy and wages and benefits.

Conference call and webcast

Loblaw Companies will host a conference call as well as an audio webcast on April 30, 2014, at 11 a.m. (ET).

To access via teleconference please dial 416-642-5212. The playback will be made available two hours after the event at 647-436-0148, access code: 6056008. To access via audio webcast please visit the company's website, go to investor centre and click on webcast. Preregistration will be available.

Annual meeting of shareholders

The 2014 annual meeting of shareholders of Loblaw Companies will be held on Thursday, May 1, 2014, at 11 a.m. (ET), at the Mattamy Athletic Centre, 50 Carlton St., Toronto, M5B 1J2.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.